Biblio

2018
Schuster S, Saravanakumar S, Schöls L, Hauser S. Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for the STUB1 locus. Stem Cell Res. 2018;34:101378.
Hennig AFloriane, Rössler U, Boiti F, von der Hagen M, Gossen M, Kornak U, Stachelscheid H. Generation of a human induced pluripotent stem cell line (BIHi002-A) from a patient with CLCN7-related infantile malignant autosomal recessive osteopetrosis. Stem Cell Res. 2018;35:101367.
Choi HYoung, Kim S-J, Go GYoun, Kwon A, Im YSam, Ha H-Y, Hong JTae, Jung J-W, Koo SKyung. Generation of a human induced pluripotent stem cell line, KSCBi003-A, from human adipose tissue-derived mesenchymal stem cells using a chromosomal integration-free system. Stem Cell Res. 2018;31:1-4.
García-León JAntonio, Cabrera-Socorro A, Eggermont K, Swijsen A, Terryn J, Fazal R, Nami FA, Ordovas L, Quiles A, Lluis F, et al. Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein tau mutations which displays several phenotypes linked to neurodegeneration. Alzheimers Dement. 2018.
Calado SM, Garcia-Delgado AB, De la Cerda B, Ponte-Zuñiga B, Bhattacharya SS, Díaz-Corrales FJ. Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation. Stem Cell Res. 2018;33:251-254.
Arellano CMachuca, Vilches A, Clemente E, Pascual-Pascual SIgnacio, Bolinches-Amorós A, Castro AArtero, Espinos C, Rodriguez MLeon, Jendelová P, Erceg S. Generation of a human iPSC line from a patient with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) caused by mutation in SACSIN gene. Stem Cell Res. 2018;31:249-252.
Lukovic D, Castro AArtero, León M, Furió VDel Buey, Cortón M, Ayuso C, Erceg S. Generation of a human iPSC line from a patient with Leber congenital amaurosis caused by mutation in AIPL1. Stem Cell Res. 2018;33:151-155.
Sanjurjo-Soriano C, Erkilic N, Manes G, Dubois G, Hamel CP, Meunier I, Kalatzis V. Generation of a human iPSC line, INMi002-A, carrying the most prevalent USH2A variant associated with Usher syndrome type 2. Stem Cell Res. 2018;33:247-250.
Gagne AL, Maguire JAnn, Gandre-Babbe S, Chou ST, Tasian SK, Loh ML, Weiss MJ, Gadue P, French DL. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL. Stem Cell Res. 2018;31:157-160.
Baulier E, Diaz AGarcia, Corneo B, Farber DB. Generation of a human Ocular Albinism type 1 iPSC line, SEIi001-A, with a mutation in GPR143. Stem Cell Res. 2018;33:274-277.
Cao Y, Xu J, Wen J, Ma X, Liu F, Li Y, Chen W, Sun L, Wu Y, Li S, et al. Generation of a Urine-Derived Ips Cell Line from a Patient with a Ventricular Septal Defect and Heart Failure and the Robust Differentiation of These Cells to Cardiomyocytes via Small Molecules. Cell Physiol Biochem. 2018;50(2):538-551.
Tamo L, Hibaoui Y, Kallol S, Alves MP, Albrecht C, Hostettler KE, Feki A, Rougier J-S, Abriel H, Knudsen L, et al. Generation of an alveolar epithelial type II cell line from induced pluripotent stem cells. Am J Physiol Lung Cell Mol Physiol. 2018.
Schöndorf DC, Elschami M, Schieck M, Ercan-Herbst E, Weber C, Riesinger Y, Kalman S, Steinemann D, Ehrnhoefer DE. Generation of an induced pluripotent stem cell cohort suitable to investigate sporadic Alzheimer's Disease. Stem Cell Res. 2018;34:101351.
Schwarz N, Uysal B, Rosa F, Löffler H, Mau-Holzmann UA, Liebau S, Lerche H. Generation of an induced pluripotent stem cell (iPSC) line from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Leu328Val) mutation. Stem Cell Res. 2018;33:6-9.
Holliday M, Ross SBarratt, Lim S, Semsarian C. Generation of an induced pluripotent stem cell line from a hypertrophic cardiomyopathy patient with a pathogenic myosin binding protein C (MYBPC3) p.Arg502Trp mutation. Stem Cell Res. 2018;33:56-59.
Hayer SNicole, Schelling Y, Hoeflinger P, Hauser S, Schöls L. Generation of an induced pluripotent stem cell line from a patient with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): HIHCNi003-A. Stem Cell Res. 2018;30:206-209.
Hayer SNicole, Schelling Y, Huebener-Schmid J, Weber JJeremiasz, Hauser S, Schöls L. Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A. Stem Cell Res. 2018;30:171-174.
Jewell BE, Liu M, Lu L, Zhou R, Tu J, Zhu D, Huo Z, Xu A, Wang D, Mata H, et al. Generation of an induced pluripotent stem cell line from an individual with a heterozygous RECQL4 mutation. Stem Cell Res. 2018;33:36-40.
Li R, Pradhan M, Xu M, Baskfield A, Farkhondeh A, Cheng Y-S, Beers J, Zou J, Liu C, Might M, et al. Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene. Stem Cell Res. 2018;34:101362.
Lu Y-Q, Dong E-L, Yang W-Q, Lai L-L, Lin X-H, Ma L-X, Chen W-J, Wang N, Lin X. Generation of an integration-free induced pluripotent stem cell line, FJMUi001-A, from a hereditary spastic paraplegia patient carrying compound heterozygous p.P498L and p.R618W mutations in CAPN1 (SPG76). Stem Cell Res. 2018;34:101354.
Wei R, Han H, Ye M, He L, Lei Q, Zhou T, Cai X, Li Z. Generation of an integration-free iPSC line(SYSUi001-A) from a sporadic Alzheimer's disease patient. Stem Cell Res. 2018;35:101375.
Sanjurjo-Soriano C, Erkilic N, Manes G, Dubois G, Hamel CP, Meunier I, Kalatzis V. Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa. Stem Cell Res. 2018;33:228-232.
Neureiter A, Brändl B, Hiber M, Tandon R, Müller F-J, Steenpass L. Generation of an iPSC line of a patient with Angelman syndrome due to an imprinting defect. Stem Cell Res. 2018;33:20-24.
Seshadri N, Sandhu S, Wu X, Liu W, Ding H. Generation of an Rtel1-CreERT2 knock-in mouse model for lineage tracing RTEL1+ stem cells during development. Transgenic Res. 2018.
Zhao Z, Ji S, Shi Z, Liu H. Generation of CSi001-A, a transgene-free, induced pluripotent stem cell line derived from a Parkinson Disease (PD) patient. Stem Cell Res. 2018;33:1-5.

Pages